Complaint filed in federal court seeking an injunction to stop the agency from illegally spying on employees' private communications to Congress and other oversight agencies.
FDA Intercepts: Draft Whistleblower Disclosures to Office of Special Counsel (OSC)
Gmail Intercept - FDA intercepted confidential attorney-client communications when the whistleblower was preparing to file an EEO retaliation case against FDA managers. The first page is a screen shot of the employee's computer. The rest of the document is the draft letter.
FDA Intercepts: Communications to Congress
Congressional Intercept #1 - 2009 emails between FDA whistleblower Paul T. Hardy and Joanne Royce, former staff member for the House Committee on Energy and Commerce (Document produced by FDA)
Congressional Intercept #2 - 2009 emails between FDA whistleblower Paul T. Hardy and Joanne Royce, former staff member for the House Committee on Energy and Commerce (Document produced by FDA)
Congressional Intercept #2b - Close-up of FDA internal filing system referring to the whistleblowers as the "FDA9"
Congressional Intercept #3 - Emails between FDA whistleblower Paul T. Hardy and Emila, former Chief Investigator for Senate Finance Committee (Document produced by FDA)
Congressional Intercept #4 - COMING SOON
FDA Intercept: Gmail-to-Gmail Communications
Gmail Intercept #1 - Whistleblowers discussing how stressful it is to "keep fighting the fight" and encouraging each other to "hang in there"
Gmail Intercept #2 - COMING SOON
FDA Intercepts: Screen Shots
Screen Shot #1 - Confidential attorney-client communications when the whistleblower was preparing to file an EEO retaliation case against FDA managers
Screen Shot #2 - Confidential attorney-client communications between the whistleblowers
Screen Shot #3 - The surveillance permitted FDA to learn identity of anyone communicating with the whistleblowers
Screen Shot #4 - Photo of one of whistleblower's dogs on their screen. Shows that once the FDA commenced the surveillance, they intercepted emails that contained purely personal communications that did not have a legitimate government interest. The emails were intercepted to discredit, intimidate, and threaten the whistleblowers
(Produced by the FDA)
Related FDA Documents
HHS OIG Letter to FDA stating whistleblowers' disclosures are lawful and protected
Internal FDA Emails - Emails showing the the screen shots of the whistleblowers' computers were being widely shared by FDA managers
HHS OIG Email - Emails showing that HHS OIG advised the whistleblowers to preserve their emails supporting their whistleblowing "offline" of the FDA email system